Ressources

Bienvenue dans notre banque interrogeable de ressources et de documentation sur l’approvisionnement plus sécuritaire et autres sujets connexes.

‘Safer opioid distribution’ as an essential public health intervention for the opioid mortality crisis – Considerations, options and examples towards broad-based implementation

Commentary | 2020

Harm reduction, Policy/Regulatory, Safer supply

Advocating for diamorphine: Cosmopolitical care and collective action in the ruins of the ‘old British system’

Argue through the accounts of advocates and patients for the continuation of these flexible and hidden modes of caring with diamorphine as not merely a form of supporting individuals’ rights (to ca

Original research | 2020

Policy/Regulatory, Advocacy, Barriers and enablers

Bioequivalence Following Buccal and Sublingual Placement of Fentanyl Buccal Tablet 400μg in Healthy Subjects

FBT is indicated for the management of breakthrough pain (a transient flare of pain on a background of chronic pain otherwise controlled by treatment with opioids) in patients with cancer who are alre

Original research | 2008

Clinical guidance, About prescribers, Chronic pain

Can touch this: training to correct police officer beliefs about overdose from incidental contact with fentanyl

To better understand the potential of police education interventions in correcting false beliefs about fentanyl

Original research | 2021

Overdose, Legal system/law enforcement, Illegal drugs

Clinical Management of Cannabis Withdrawal

This review describes the diagnosis, prevalence, course and management of cannabis withdrawal and highlights opportunities for future clinical research.

Lit review | 2021

Withdrawal, Clinical guidance

Closed-loop wearable naloxone injector system

There remains a critical need for technologies to administer naloxone in the event of unwitnessed overdose events.

Original research | 2021

Overdose, Harm reduction, Illegal drugs, Digital health

Comparison of Equivalent Doses of Fentanyl Buccal Tablets and Arteriovenous Differences in Fentanyl Pharmacokinetics

Assess whether 4x100μg fentanyl buccal tablets had the same biological effect as 1 400μg tablet

Original research | 2006

Clinical guidance, About prescribers

Consumer protection in drug policy: The human rights case for safe supply as an element of harm reduction

Examines the human rights justification for incorporating safe supply as an important element of the HR pillar of drug policy.

Commentary | 2020

Policy/Regulatory, Safer supply, Advocacy, Illegal drugs, Peer/PWLLE program involvement

Decolonizing drug policy

This paper reviews evidence of how drug control has been used to uphold colonial power structures in select countries.

Scoping review | 2021

Policy/Regulatory, Safer supply, Decriminalization/legalization, Equity, Advocacy, Social services, Illegal drugs

Drug risk perception and risk management strategies among Israeli functioning drug users: a qualitative exploration

Examining how functioning people who are in the process of building their careers or family lives perceive and manage the risks and harms of drug use.

Original research | 2021

Harm reduction, About PWUD, Illegal drugs

Drug risk perception and risk management strategies among Israeli functioning drug users: a qualitative exploration

Examines how functioning people who are in the process of building their careers or family lives perceive and manage the risks and harms of drug use

Original research | 2021

Harm reduction, About PWUD, Illegal drugs, Social benefits

Emergency department presentations in the first weeks following release from prison among men with a history of injecting drug use in Victoria, Australia: A prospective cohort study

Rates of emergency department (ED) use are higher among people released from prison than in the general population.

Original research | 2022

Harm reduction, About PWUD, Social services, Outcomes, Housing, Legal system/law enforcement, Illegal drugs, Sex/Gender , Mental health, Hospitals

Exposure to fentanyl-contaminated heroin and overdose risk among illicit opioid users in Rhode Island: A mixed methods study

This study describes patterns and perceptions of fentanyl exposure among opioid users in Rhode Island.

Original research | 2017

Evidence base, Harm reduction, Safer supply, Illegal drugs

Hospital Buprenorphine Program for Opioid Use Disorder Is Associated With Increased Inpatient and Outpatient Addiction Treatment

This study reports the outcomes of the B-Team (Buprenorphine-Team), a hospitalist-led interprofessional program created to identify hospitalized patients with OUD, initiate buprenorphine in the inpati

Original research | 2021

Clinical guidance, Evidence base, Wrap-around services, About prescribers, Outcomes, Substitution/OAT, Transitions in care/treatment, Hospitals